https://medicaex.com/businesswire/teva-announces-unique-collaboration-with-healthsnap-to-expand-the-reach-of-its-respiratory-digital-health-platform-3/ 2022-11-14T13:12:13+00:00 https://medicaex.com/wp-content/uploads/2022/11/teva_RGB_JPEG-CqyoQd.jpeg https://medicaex.com/businesswire/teva-announces-unique-collaboration-with-healthsnap-to-expand-the-reach-of-its-respiratory-digital-health-platform-2/ 2022-11-14T13:12:11+00:00 https://medicaex.com/wp-content/uploads/2022/11/teva_RGB_JPEG-7bjzyQ.jpeg https://medicaex.com/businesswire/perkinelmer-announces-its-eonis-scid-sma-kit-is-first-to-receive-marketing-authorization-by-u-s-fda-for-sma-screening-in-newborns/ 2022-11-14T13:12:11+00:00 https://medicaex.com/businesswire/charles-river-laboratories-to-present-at-november-investor-conferences/ 2022-11-14T13:12:11+00:00 https://medicaex.com/wp-content/uploads/2022/11/charles_river_logo-U13m9y.jpeg https://medicaex.com/businesswire/preliminary-data-from-aaa-shape-to-be-presented-at-veith-2022/ 2022-11-14T13:12:11+00:00 https://medicaex.com/wp-content/uploads/2022/11/SMM_LOGO_SF_BLUE_R-siMU9H.jpeg https://medicaex.com/businesswire/orionis-biosciences-presents-preclinical-data-on-interferon-and-il-2-targeted-cytokine-immunotherapies-for-cancer/ 2022-11-14T13:12:08+00:00 https://medicaex.com/wp-content/uploads/2022/11/Orionis_Logo_web_Antracite-01-fFitIc.jpeg https://medicaex.com/businesswire/teva-announces-unique-collaboration-with-rimidi-to-expand-the-reach-of-its-respiratory-digital-health-platform/ 2022-11-14T13:12:07+00:00 https://medicaex.com/wp-content/uploads/2022/11/teva_RGB_JPEG-DeR3i7.jpeg https://medicaex.com/businesswire/vbi-vaccines-to-participate-in-upcoming-investor-conferences/ 2022-11-14T13:12:07+00:00 https://medicaex.com/wp-content/uploads/2022/11/VBI_Vaccines_Logo_Horiz_RGB-Esocwh.jpeg https://medicaex.com/businesswire/teva-announces-unique-collaboration-with-healthsnap-to-expand-the-reach-of-its-respiratory-digital-health-platform/ 2022-11-14T13:12:07+00:00 https://medicaex.com/wp-content/uploads/2022/11/teva_RGB_JPEG-228rJr.jpeg https://medicaex.com/businesswire/mvm-closes-oversubscribed-fund-at-500-million-hard-cap/ 2022-11-14T13:12:06+00:00 https://medicaex.com/wp-content/uploads/2022/11/MVM_white_logo_jpeg-9X0sOx.jpeg https://medicaex.com/businesswire/docgo-appoints-veteran-technology-human-resources-executive-vina-leite-ms-to-its-board-of-directors-and-announces-key-leadership-promotions/ 2022-11-14T13:12:04+00:00 https://medicaex.com/wp-content/uploads/2022/11/DocGo_Primaray_Logo_2022-aUzaDP.jpeg https://medicaex.com/businesswire/alight-expands-holistic-wellbeing-solutions-with-the-addition-of-hinge-health-and-quit-genius-to-partner-network/ 2022-11-14T13:12:03+00:00 https://medicaex.com/wp-content/uploads/2022/11/Alight_Logo_RGB_Black28129-okvwqy.jpeg https://medicaex.com/businesswire/virios-therapeutics-announces-third-quarter-2022-financial-results-and-provides-corporate-update-2/ 2022-11-14T12:12:14+00:00 https://medicaex.com/wp-content/uploads/2022/11/Virios_Logo_Blue-apE0KS.jpeg https://medicaex.com/businesswire/trisalus-life-sciences-to-become-publicly-traded-through-merger-with-medtech-acquisition-corporation-2/ 2022-11-14T12:12:14+00:00 https://medicaex.com/businesswire/enanta-pharmaceuticals-to-host-conference-call-on-november-21-at-430-p-m-et-to-discuss-its-financial-results-for-its-fiscal-fourth-quarter-and-full-year-ended-september-30-2022-2/ 2022-11-14T12:12:14+00:00 https://medicaex.com/wp-content/uploads/2022/11/Enanta_RGB-5wm5nK.jpeg https://medicaex.com/businesswire/exscientia-and-md-anderson-launch-strategic-collaboration-to-leverage-ai-in-developing-novel-oncology-treatments-2/ 2022-11-14T12:12:14+00:00 https://medicaex.com/wp-content/uploads/2022/11/Exscientia_logo-01-S5v5rs.jpeg https://medicaex.com/businesswire/infinity-pharmaceuticals-reports-third-quarter-2022-financial-results-and-provides-business-update-2/ 2022-11-14T12:12:14+00:00 https://medicaex.com/wp-content/uploads/2022/11/INFI_LOGO_TM_RGB-VgYDqd.jpeg https://medicaex.com/businesswire/sambanova-delivers-next-generation-datascale-system-to-argonne-national-laboratory/ 2022-11-14T12:12:11+00:00 https://medicaex.com/wp-content/uploads/2022/11/Marshall_Choy2C_SambaNova_Systems_and_Rick_Stevens2C_Argonne_National_Laboratory-TVPmCL.jpeg https://medicaex.com/businesswire/foundation-medicine-launches-foundationreport-a-new-digital-reporting-experience-to-streamline-precision-cancer-care-2/ 2022-11-14T12:12:10+00:00 https://medicaex.com/wp-content/uploads/2022/11/FMI_horizontal-AtU4QU.jpeg https://medicaex.com/businesswire/bruker-announces-agreement-to-acquire-neurescence-inc-bolstering-neuroscience-research-portfolio/ 2022-11-14T12:12:10+00:00 https://medicaex.com/wp-content/uploads/2022/11/Bruker_logo-2zmawS.jpeg https://medicaex.com/businesswire/exscientia-and-md-anderson-launch-strategic-collaboration-to-leverage-ai-in-developing-novel-oncology-treatments/ 2022-11-14T12:12:10+00:00 https://medicaex.com/wp-content/uploads/2022/11/Exscientia_logo-01-RbtOq2.jpeg https://medicaex.com/businesswire/castle-biosciences-named-a-houston-chronicle-top-workplace-for-the-second-consecutive-year-2/ 2022-11-14T12:12:09+00:00 https://medicaex.com/wp-content/uploads/2022/11/CastleLogo2Color-8Ymdu6.jpeg https://medicaex.com/businesswire/xironetic-receives-fda-clearance-for-augmented-reality-surgical-software/ 2022-11-14T12:12:09+00:00 https://medicaex.com/wp-content/uploads/2022/11/Xironetic_logo-U5OwFb.jpeg https://medicaex.com/businesswire/908-devices-reports-third-quarter-2022-financial-results-and-updates-full-year-2022-outlook/ 2022-11-14T12:12:08+00:00 https://medicaex.com/businesswire/castle-biosciences-named-a-houston-chronicle-top-workplace-for-the-second-consecutive-year/ 2022-11-14T12:12:07+00:00 https://medicaex.com/wp-content/uploads/2022/11/CastleLogo2Color-vxHftE.jpeg https://medicaex.com/businesswire/feminine-wipes-global-market-report-2022-featuring-major-players-albaad-massuot-yitzhak-corman-la-fresh-group-guy-oneill-healthy-hoohoo-researchandmarkets-com/ 2022-11-14T12:12:07+00:00 https://medicaex.com/wp-content/uploads/2022/11/logo-jaO1JH.jpeg https://medicaex.com/businesswire/infinity-pharmaceuticals-reports-third-quarter-2022-financial-results-and-provides-business-update/ 2022-11-14T12:12:05+00:00 https://medicaex.com/wp-content/uploads/2022/11/INFI_LOGO_TM_RGB-E6XU2g.jpeg https://medicaex.com/businesswire/virios-therapeutics-announces-third-quarter-2022-financial-results-and-provides-corporate-update/ 2022-11-14T12:12:05+00:00 https://medicaex.com/wp-content/uploads/2022/11/Virios_Logo_Blue-kdhfqq.jpeg https://medicaex.com/businesswire/infinity-pharmaceuticals-provides-mario-3-update-in-patients-with-front-line-metastatic-triple-negative-breast-cancer-suggesting-potential-long-term-patient-benefit-of-eganelisib/ 2022-11-14T12:12:05+00:00 https://medicaex.com/wp-content/uploads/2022/11/INFI_LOGO_TM_RGB-FnnlTY.jpeg https://medicaex.com/businesswire/trisalus-life-sciences-to-become-publicly-traded-through-merger-with-medtech-acquisition-corporation/ 2022-11-14T12:12:05+00:00 https://medicaex.com/businesswire/enanta-pharmaceuticals-to-host-conference-call-on-november-21-at-430-p-m-et-to-discuss-its-financial-results-for-its-fiscal-fourth-quarter-and-full-year-ended-september-30-2022/ 2022-11-14T12:12:05+00:00 https://medicaex.com/wp-content/uploads/2022/11/Enanta_RGB-tNECsa.jpeg https://medicaex.com/businesswire/gabelli-funds-and-columbia-business-school-to-host-4th-annual-healthcare-symposium/ 2022-11-14T12:12:04+00:00 https://medicaex.com/businesswire/foundation-medicine-launches-foundationreport-a-new-digital-reporting-experience-to-streamline-precision-cancer-care/ 2022-11-14T12:12:03+00:00 https://medicaex.com/wp-content/uploads/2022/11/FMI_horizontal-olivIk.jpeg https://medicaex.com/businesswire/rhinostics-and-lvl-technologies-partner-to-provide-decapping-solutions-for-automated-collection-device-workflows-4/ 2022-11-14T11:12:14+00:00 https://medicaex.com/wp-content/uploads/2022/11/RHINObot_Nov_13_Final-A3fHyu.jpeg https://medicaex.com/businesswire/rockwell-medical-provides-business-strategy-update-and-announces-third-quarter-2022-financial-and-operational-results-3/ 2022-11-14T11:12:14+00:00 https://medicaex.com/wp-content/uploads/2022/11/Rockwell_Medical_-_logo_-_BusinessWire-jLdsbW.jpeg https://medicaex.com/businesswire/rhinostics-and-lvl-technologies-partner-to-provide-decapping-solutions-for-automated-collection-device-workflows-3/ 2022-11-14T11:12:11+00:00 https://medicaex.com/wp-content/uploads/2022/11/RHINObot_Nov_13_Final-mUjAO6.jpeg https://medicaex.com/businesswire/rhinostics-and-lvl-technologies-partner-to-provide-decapping-solutions-for-automated-collection-device-workflows-2/ 2022-11-14T11:12:09+00:00 https://medicaex.com/wp-content/uploads/2022/11/RHINObot_Nov_13_Final-GqDae8.jpeg https://medicaex.com/businesswire/rockwell-medical-provides-business-strategy-update-and-announces-third-quarter-2022-financial-and-operational-results-2/ 2022-11-14T11:12:09+00:00 https://medicaex.com/wp-content/uploads/2022/11/Rockwell_Medical_-_logo_-_BusinessWire-9qP7JR.jpeg https://medicaex.com/businesswire/rhinostics-and-lvl-technologies-partner-to-provide-decapping-solutions-for-automated-collection-device-workflows/ 2022-11-14T11:12:07+00:00 https://medicaex.com/wp-content/uploads/2022/11/RHINObot_Nov_13_Final-CUmmXb.jpeg https://medicaex.com/businesswire/rockwell-medical-provides-business-strategy-update-and-announces-third-quarter-2022-financial-and-operational-results/ 2022-11-14T11:12:07+00:00 https://medicaex.com/wp-content/uploads/2022/11/Rockwell_Medical_-_logo_-_BusinessWire-NS56S4.jpeg https://medicaex.com/businesswire/revitalist-and-wake-network-announce-joint-venture-partnership-to-open-psychedelic-clinics-and-retreats-in-the-united-states/ 2022-11-14T11:12:05+00:00 https://medicaex.com/wp-content/uploads/2022/11/Revitalist_text_logo-2-hMD4g0.jpeg https://medicaex.com/businesswire/apollo-therapeutics-and-the-institute-of-cancer-research-enter-into-collaboration-for-cancer-drug-development-2/ 2022-11-14T10:12:09+00:00 https://medicaex.com/wp-content/uploads/2022/11/Apollo_Logo_2022-jEfGoO.jpeg https://medicaex.com/businesswire/apollo-therapeutics-and-the-institute-of-cancer-research-enter-into-collaboration-for-cancer-drug-development/ 2022-11-14T10:12:03+00:00 https://medicaex.com/wp-content/uploads/2022/11/Apollo_Logo_2022-SGTR1j.jpeg https://medicaex.com/businesswire/epiendo-commences-phase-2a-trial-for-ep395-in-copd-patients-2/ 2022-11-14T09:12:14+00:00 https://medicaex.com/wp-content/uploads/2022/11/banner_version_-_Large_-_New_Colour-qoTyVJ.jpeg https://medicaex.com/businesswire/middle-east-healthcare-community-reunites-in-saudi-arabia-to-reimagine-health-at-himss22-middle-east-2/ 2022-11-14T09:12:12+00:00 https://medicaex.com/wp-content/uploads/2022/11/HIMSSlogo_Hfullcolor_RGB-fEIt0x.jpeg https://medicaex.com/businesswire/dexcom-invites-the-diabetes-community-to-seediabetes-this-november-and-share-their-diabetes-story-with-custom-continuous-glucose-monitor-cgm-patches/ 2022-11-14T09:12:11+00:00 https://medicaex.com/wp-content/uploads/2022/11/WDD_Patches-GdAUBW.jpeg https://medicaex.com/businesswire/epiendo-commences-phase-2a-trial-for-ep395-in-copd-patients/ 2022-11-14T09:12:07+00:00 https://medicaex.com/wp-content/uploads/2022/11/banner_version_-_Large_-_New_Colour-QXp2Ac.jpeg https://medicaex.com/businesswire/middle-east-healthcare-community-reunites-in-saudi-arabia-to-reimagine-health-at-himss22-middle-east/ 2022-11-14T09:12:06+00:00 https://medicaex.com/wp-content/uploads/2022/11/HIMSSlogo_Hfullcolor_RGB-qcvOhi.jpeg https://medicaex.com/businesswire/medimaps-group-announces-partnership-with-osteosys-to-bring-trabecular-bone-score-to-koreas-leading-bone-densitometry-platform/ 2022-11-14T08:12:07+00:00 https://medicaex.com/wp-content/uploads/2022/11/TBSinsight-3CKZ7N.jpeg https://medicaex.com/businesswire/enhertu-recommended-for-approval-in-the-eu-by-chmp-for-patients-with-previously-treated-her2-positive-advanced-gastric-cancer-2/ 2022-11-14T07:12:12+00:00 https://medicaex.com/wp-content/uploads/2022/11/DaiichiSankyo-logo-cQmIrh.jpeg https://medicaex.com/businesswire/transgene-and-bioinvent-joint-paper-on-bt-001-wins-jitc-best-oncolytic-and-local-immunotherapy-paper-award-for-2022-2/ 2022-11-14T07:12:12+00:00 https://medicaex.com/wp-content/uploads/2022/11/Logo_Transgene-W2mG4E.jpeg https://medicaex.com/businesswire/jabil-opens-new-design-center-to-support-sector-growth/ 2022-11-14T07:12:09+00:00 https://medicaex.com/wp-content/uploads/2022/11/jabil-wroclaw-design-center-ribbon-cutting-EJo7rR.jpeg https://medicaex.com/businesswire/transgene-and-bioinvent-joint-paper-on-bt-001-wins-jitc-best-oncolytic-and-local-immunotherapy-paper-award-for-2022/ 2022-11-14T07:12:07+00:00 https://medicaex.com/wp-content/uploads/2022/11/Logo_Transgene-H61Bjm.jpeg https://medicaex.com/businesswire/enhertu-recommended-for-approval-in-the-eu-by-chmp-for-patients-with-previously-treated-her2-positive-advanced-gastric-cancer/ 2022-11-14T07:12:06+00:00 https://medicaex.com/wp-content/uploads/2022/11/DaiichiSankyo-logo-SeG6fS.jpeg https://medicaex.com/businesswire/genentech-provides-update-on-phase-iii-graduate-program-evaluating-gantenerumab-in-early-alzheimers-disease-2/ 2022-11-14T06:12:10+00:00 https://medicaex.com/wp-content/uploads/2022/11/genentech_day02_ditl_28798.2_flat_rgb_hi_28129-Y83Xkp.jpeg https://medicaex.com/businesswire/innate-pharma-reports-third-quarter-financial-results-2/ 2022-11-14T06:12:10+00:00 https://medicaex.com/wp-content/uploads/2022/11/INNATEvertnoirDS-vsImq6.jpeg https://medicaex.com/businesswire/genentech-provides-update-on-phase-iii-graduate-program-evaluating-gantenerumab-in-early-alzheimers-disease/ 2022-11-14T06:12:05+00:00 https://medicaex.com/wp-content/uploads/2022/11/genentech_day02_ditl_28798.2_flat_rgb_hi_28129-h8wFG0.jpeg https://medicaex.com/businesswire/innate-pharma-reports-third-quarter-financial-results/ 2022-11-14T06:12:05+00:00 https://medicaex.com/wp-content/uploads/2022/11/INNATEvertnoirDS-kTKgLD.jpeg https://medicaex.com/businesswire/world-first-inhaled-covid-19-vaccine-developed-in-partnership-between-aerogen-and-cansinobio-first-public-booster-immunization-in-china/ 2022-11-14T05:12:04+00:00 https://medicaex.com/wp-content/uploads/2022/11/1-KUqhh2.jpeg https://medicaex.com/businesswire/innocare-releases-2022-third-quarter-results-star-board-listing-for-long-term-growth-and-rapid-increase-of-orelabrutinib-sales-2/ 2022-11-14T01:12:08+00:00 https://medicaex.com/businesswire/innocare-releases-2022-third-quarter-results-star-board-listing-for-long-term-growth-and-rapid-increase-of-orelabrutinib-sales/ 2022-11-14T01:12:04+00:00 https://medicaex.com/businesswire/coeus-h3c-to-deliver-easy-friction-free-experience-for-home-health-customers/ 2022-11-13T14:12:07+00:00 https://medicaex.com/wp-content/uploads/2022/11/Coeus_logo.11.11.22-6beBkJ.jpeg https://medicaex.com/businesswire/sparrow-pharmaceuticals-presents-pharmacology-data-on-spi-62-at-american-college-of-rheumatology-convergence-2022-2/ 2022-11-13T13:12:09+00:00 https://medicaex.com/wp-content/uploads/2022/11/sparrow_logo-wnnoiV.jpeg https://medicaex.com/businesswire/sparrow-pharmaceuticals-presents-pharmacology-data-on-spi-62-at-american-college-of-rheumatology-convergence-2022/ 2022-11-13T13:12:04+00:00 https://medicaex.com/wp-content/uploads/2022/11/sparrow_logo-hpcXRQ.jpeg https://medicaex.com/businesswire/kezar-announces-inducement-grant-under-nasdaq-listing-rule-5635c4-2/ 2022-11-11T21:14:00+00:00 https://medicaex.com/wp-content/uploads/2022/11/Kezar_Life_Sciences_logo_July_2022-d11klu.jpeg https://medicaex.com/businesswire/kezar-announces-inducement-grant-under-nasdaq-listing-rule-5635c4/ 2022-11-11T21:12:04+00:00 https://medicaex.com/wp-content/uploads/2022/11/Kezar_Life_Sciences_logo_July_2022-FF1XqZ.jpeg https://medicaex.com/businesswire/antidote-health-helping-families-devastated-by-hurricane-nicole/ 2022-11-11T20:12:07+00:00 https://medicaex.com/wp-content/uploads/2022/11/Antidote_Logo_Orange26Blue-fTzaJK.jpeg https://medicaex.com/businesswire/nutcracker-therapeutics-reports-strong-anti-tumor-responses-of-lead-mrna-immunotherapy-in-preclinical-data-presented-at-sitc-annual-meeting-2022-2/ 2022-11-11T19:12:44+00:00 https://medicaex.com/wp-content/uploads/2022/11/Nutcracker_Logo-ymVeC8.jpeg https://medicaex.com/businesswire/nutcracker-therapeutics-reports-strong-anti-tumor-responses-of-lead-mrna-immunotherapy-in-preclinical-data-presented-at-sitc-annual-meeting-2022/ 2022-11-11T19:12:05+00:00 https://medicaex.com/wp-content/uploads/2022/11/Nutcracker_Logo-GMdRxk.jpeg https://medicaex.com/businesswire/lateral-flow-immunoassay-lfia-based-rapid-test-global-market-report-2022-multiplex-detection-assays-present-lucrative-opportunities-researchandmarkets-com-3/ 2022-11-11T18:12:15+00:00 https://medicaex.com/wp-content/uploads/2022/11/logo-ZlYSVd.jpeg https://medicaex.com/businesswire/medable-named-a-leader-in-decentralized-clinical-trial-products-assessment-for-second-consecutive-year-by-everest-group-2/ 2022-11-11T18:12:15+00:00 https://medicaex.com/wp-content/uploads/2022/11/Medable_Everest_Peak_Matrix_DCT_Leader_Press_Release-qsQbvl.jpeg https://medicaex.com/businesswire/united-states-intensive-care-unit-icu-clinical-decision-support-solutions-cdss-market-report-2022-analyzing-the-emerging-trends-that-are-influencing-this-space-researchandmarkets-com/ 2022-11-11T18:12:13+00:00 https://medicaex.com/wp-content/uploads/2022/11/logo-EH5OGn.jpeg https://medicaex.com/businesswire/the-worldwide-patient-temperature-monitoring-industry-is-projected-to-reach-4-9-billion-by-2027-researchandmarkets-com/ 2022-11-11T18:12:08+00:00 https://medicaex.com/wp-content/uploads/2022/11/logo-hLJCqx.jpeg https://medicaex.com/businesswire/lateral-flow-immunoassay-lfia-based-rapid-test-global-market-report-2022-multiplex-detection-assays-present-lucrative-opportunities-researchandmarkets-com-2/ 2022-11-11T18:12:07+00:00 https://medicaex.com/wp-content/uploads/2022/11/logo-Ub2BCC.jpeg https://medicaex.com/businesswire/lateral-flow-immunoassay-lfia-based-rapid-test-global-market-report-2022-multiplex-detection-assays-present-lucrative-opportunities-researchandmarkets-com/ 2022-11-11T18:12:06+00:00 https://medicaex.com/wp-content/uploads/2022/11/logo-KwMUcd.jpeg https://medicaex.com/businesswire/medable-named-a-leader-in-decentralized-clinical-trial-products-assessment-for-second-consecutive-year-by-everest-group/ 2022-11-11T18:12:05+00:00 https://medicaex.com/wp-content/uploads/2022/11/Medable_Everest_Peak_Matrix_DCT_Leader_Press_Release-MZizIT.jpeg https://medicaex.com/businesswire/pharmas-vaccine-tech-hoarding-kills-says-ahf/ 2022-11-11T18:12:04+00:00 https://medicaex.com/wp-content/uploads/2022/11/51691880270_53873f4592_o-NZEJ4M.jpeg https://medicaex.com/businesswire/droplettes-micro-infuser-device-named-to-times-best-inventions-of-2022-list/ 2022-11-11T17:12:08+00:00 https://medicaex.com/wp-content/uploads/2022/11/radiant-6cobalt-NAdV5D.jpeg https://medicaex.com/businesswire/2-6-billion-worldwide-vacuum-blood-collection-tube-industry-to-2029-increasing-consumer-awareness-of-the-importance-of-maintaining-a-healthy-lifestyle-is-driving-growth-researchandmarkets-com/ 2022-11-11T17:12:06+00:00 https://medicaex.com/wp-content/uploads/2022/11/logo-q0ey08.jpeg https://medicaex.com/businesswire/global-companion-diagnostics-market-report-2022-rising-consumer-preference-for-focused-therapy-and-personalized-medicine-presents-opportunities-researchandmarkets-com-2/ 2022-11-11T16:12:13+00:00 https://medicaex.com/wp-content/uploads/2022/11/logo-ZCclT6.jpeg https://medicaex.com/businesswire/global-companion-diagnostics-market-report-2022-rising-consumer-preference-for-focused-therapy-and-personalized-medicine-presents-opportunities-researchandmarkets-com/ 2022-11-11T16:12:06+00:00 https://medicaex.com/wp-content/uploads/2022/11/logo-HZRFC9.jpeg https://medicaex.com/businesswire/pfizer-invites-public-to-view-and-listen-to-webcast-of-pfizer-discussion-at-healthcare-conference-2/ 2022-11-11T15:12:12+00:00 https://medicaex.com/wp-content/uploads/2022/11/Pfizer_Logo_Color_RGB_APPROVED-70tN8X.jpeg https://medicaex.com/businesswire/tallac-therapeutics-presents-data-for-two-first-in-class-toll-like-receptor-9-agonist-antibody-conjugates-at-the-society-for-immunotherapy-of-cancer-37th-annual-meeting-2/ 2022-11-11T15:12:12+00:00 https://medicaex.com/wp-content/uploads/2022/11/Tallac_SITC_Image-R7iTPM.jpeg https://medicaex.com/businesswire/computer-aided-drug-discovery-global-market-report-2022-artificial-intelligence-and-big-data-to-reshape-sector-moving-forward-researchandmarkets-com-2/ 2022-11-11T15:12:10+00:00 https://medicaex.com/wp-content/uploads/2022/11/logo-AKy3AE.jpeg https://medicaex.com/businesswire/global-prefilled-syringes-market-report-2022-increasing-number-of-target-complaints-and-improving-healthcare-infrastructure-boosts-sector-researchandmarkets-com-2/ 2022-11-11T15:12:07+00:00 https://medicaex.com/wp-content/uploads/2022/11/logo-EiA5MV.jpeg https://medicaex.com/businesswire/pfizer-invites-public-to-view-and-listen-to-webcast-of-pfizer-discussion-at-healthcare-conference/ 2022-11-11T15:12:05+00:00 https://medicaex.com/wp-content/uploads/2022/11/Pfizer_Logo_Color_RGB_APPROVED-kW2EP6.jpeg https://medicaex.com/businesswire/global-prefilled-syringes-market-report-2022-increasing-number-of-target-complaints-and-improving-healthcare-infrastructure-boosts-sector-researchandmarkets-com/ 2022-11-11T15:12:05+00:00 https://medicaex.com/wp-content/uploads/2022/11/logo-54Ung7.jpeg https://medicaex.com/businesswire/acorda-therapeutics-announces-passage-of-reverse-stock-split-proposal-at-its-special-meeting-of-stockholders/ 2022-11-11T15:12:05+00:00 https://medicaex.com/wp-content/uploads/2022/11/Acorda_Logo-Color_Print-z0Wrzv.jpeg https://medicaex.com/businesswire/tallac-therapeutics-presents-data-for-two-first-in-class-toll-like-receptor-9-agonist-antibody-conjugates-at-the-society-for-immunotherapy-of-cancer-37th-annual-meeting/ 2022-11-11T15:12:05+00:00 https://medicaex.com/wp-content/uploads/2022/11/Tallac_SITC_Image-KVUCr8.jpeg https://medicaex.com/businesswire/computer-aided-drug-discovery-global-market-report-2022-artificial-intelligence-and-big-data-to-reshape-sector-moving-forward-researchandmarkets-com/ 2022-11-11T15:12:04+00:00 https://medicaex.com/wp-content/uploads/2022/11/logo-tDl0Ea.jpeg https://medicaex.com/businesswire/north-america-immunodiagnostic-market-report-2022-technological-advancements-in-the-field-of-immunodiagnostics-to-shape-industry-moving-forward-researchandmarkets-com/ 2022-11-11T14:12:13+00:00 https://medicaex.com/wp-content/uploads/2022/11/logo-4xtwGh.jpeg https://medicaex.com/businesswire/global-single-use-bioreactors-market-report-2022-increasing-investments-in-the-biopharmaceutical-rd-activities-drive-growth-researchandmarkets-com/ 2022-11-11T14:12:13+00:00 https://medicaex.com/wp-content/uploads/2022/11/logo-IjSe1e.jpeg https://medicaex.com/businesswire/athersys-to-present-at-challenges-and-opportunities-for-mesenchymal-stem-cells-digital-conference-and-participate-in-a-g-p-s-biotech-conference-3/ 2022-11-11T14:12:13+00:00 https://medicaex.com/wp-content/uploads/2022/11/Athersys_logo-5vrbKW.jpeg https://medicaex.com/businesswire/global-bioactive-peptide-market-report-2022-increasing-rd-by-leading-players-driving-growth-researchandmarkets-com/ 2022-11-11T14:12:13+00:00 https://medicaex.com/wp-content/uploads/2022/11/logo-iw5UWo.jpeg https://medicaex.com/businesswire/chromadex-reports-fdas-conclusion-that-nicotinamide-mononucleotide-nmn-may-not-be-sold-or-marketed-as-a-dietary-supplement-in-the-united-states-3/ 2022-11-11T14:12:13+00:00 https://medicaex.com/wp-content/uploads/2022/11/CDX_logo_horizontal-lrg-01_copy-89WcxV.jpeg https://medicaex.com/businesswire/athersys-to-present-at-challenges-and-opportunities-for-mesenchymal-stem-cells-digital-conference-and-participate-in-a-g-p-s-biotech-conference-2/ 2022-11-11T14:12:10+00:00 https://medicaex.com/wp-content/uploads/2022/11/Athersys_logo-M1ZxUL.jpeg https://medicaex.com/businesswire/surmodics-announces-swing-trial-12-month-data-to-be-presented-at-veithsymposium-on-november-16-2/ 2022-11-11T14:12:08+00:00 https://medicaex.com/wp-content/uploads/2022/11/press_release_logo-Mm0CTa.jpeg https://medicaex.com/businesswire/pavmed-to-participate-in-btig-digital-health-forum/ 2022-11-11T14:12:08+00:00 https://medicaex.com/wp-content/uploads/2022/11/PAVM_Logo-I05PR4.jpeg https://medicaex.com/businesswire/surmodics-announces-swing-trial-12-month-data-to-be-presented-at-veithsymposium-on-november-16/ 2022-11-11T14:12:06+00:00 https://medicaex.com/wp-content/uploads/2022/11/press_release_logo-NjKMe6.jpeg https://medicaex.com/businesswire/chromadex-reports-fdas-conclusion-that-nicotinamide-mononucleotide-nmn-may-not-be-sold-or-marketed-as-a-dietary-supplement-in-the-united-states/ 2022-11-11T14:12:06+00:00 https://medicaex.com/wp-content/uploads/2022/11/CDX_logo_horizontal-lrg-01_copy-AOwcem.jpeg https://medicaex.com/businesswire/athersys-to-present-at-challenges-and-opportunities-for-mesenchymal-stem-cells-digital-conference-and-participate-in-a-g-p-s-biotech-conference/ 2022-11-11T14:12:05+00:00 https://medicaex.com/wp-content/uploads/2022/11/Athersys_logo-dg5bit.jpeg https://medicaex.com/businesswire/cyclo-therapeutics-reports-third-quarter-2022-financial-results-and-highlights-recent-achievements/ 2022-11-11T13:12:15+00:00 https://medicaex.com/businesswire/amneal-announces-u-s-fda-filing-acceptance-of-new-drug-application-for-ipx203-for-the-treatment-of-parkinsons-disease-2/ 2022-11-11T13:12:15+00:00 https://medicaex.com/wp-content/uploads/2022/11/amneallogo-JTrBaq.jpeg https://medicaex.com/businesswire/rallybio-to-present-at-upcoming-investor-conferences-in-november/ 2022-11-11T13:12:15+00:00 https://medicaex.com/wp-content/uploads/2022/11/Press_Release_Logo-2sCdWE.jpeg https://medicaex.com/businesswire/triumvira-immunologics-announces-updated-data-from-ongoing-tactic%e2%80%912-trial-of-tac01-her2-in-patients-with-her2-positive-solid-tumors/ 2022-11-11T13:12:15+00:00 https://medicaex.com/wp-content/uploads/2022/11/Triumvira_Logo_2021-eu1vOd.jpeg https://medicaex.com/businesswire/tremeau-pharmaceuticals-acr-convergence-2022-presentations-highlight-potential-path-forward-for-historical-vioxx-2/ 2022-11-11T13:12:15+00:00 https://medicaex.com/wp-content/uploads/2022/11/Tremeau_Final_Logo_Horizontal-mfp61g.jpeg https://medicaex.com/businesswire/luminopia-inc-announces-oversubscribed-seed-extension-financing-round-2/ 2022-11-11T13:12:12+00:00 https://medicaex.com/wp-content/uploads/2022/11/Luminopia_logo-WVA0Ax.jpeg https://medicaex.com/businesswire/click-therapeutics-announces-participation-in-upcoming-investor-conferences-in-november-and-december-2/ 2022-11-11T13:12:12+00:00 https://medicaex.com/wp-content/uploads/2022/11/CT_Lock-up_CMYK_Black-84Pe0B.jpeg https://medicaex.com/businesswire/microfluidics-global-market-analysis-2022-rising-demand-for-point-of-care-testing-fueling-18-79-annual-growth-researchandmarkets-com-2/ 2022-11-11T13:12:10+00:00 https://medicaex.com/wp-content/uploads/2022/11/logo-c94u19.jpeg https://medicaex.com/businesswire/ur24technology-launches-new-and-unique-trueclr-external-catheter-line/ 2022-11-11T13:12:10+00:00 https://medicaex.com/wp-content/uploads/2022/11/logo4-ZjEclF.jpeg https://medicaex.com/businesswire/endologix-announces-12-month-results-of-detour-2-trial-at-2022-viva-late-breaking-clinical-trial-session/ 2022-11-11T13:12:10+00:00 https://medicaex.com/wp-content/uploads/2022/11/logo_endo-YmXcKL.jpeg https://medicaex.com/businesswire/organ-preservation-global-market-report-2022-normothermic-machine-perfusion-as-advanced-paradigm-for-organ-preservation-presents-opportunities-researchandmarkets-com/ 2022-11-11T13:12:09+00:00 https://medicaex.com/wp-content/uploads/2022/11/logo-GLdLot.jpeg https://medicaex.com/businesswire/microfluidics-global-market-analysis-2022-rising-demand-for-point-of-care-testing-fueling-18-79-annual-growth-researchandmarkets-com/ 2022-11-11T13:12:08+00:00 https://medicaex.com/wp-content/uploads/2022/11/logo-Rk71j6.jpeg https://medicaex.com/businesswire/global-ketone-oil-market-report-2022-introduction-of-a-number-of-pharmaceutical-and-nutraceutical-supplements-rich-in-ketones-drives-growth-researchandmarkets-com/ 2022-11-11T13:12:08+00:00 https://medicaex.com/wp-content/uploads/2022/11/logo-v8E0qd.jpeg https://medicaex.com/businesswire/luminopia-inc-announces-oversubscribed-seed-extension-financing-round/ 2022-11-11T13:12:06+00:00 https://medicaex.com/wp-content/uploads/2022/11/Luminopia_logo-3sHq4F.jpeg https://medicaex.com/businesswire/amneal-announces-u-s-fda-filing-acceptance-of-new-drug-application-for-ipx203-for-the-treatment-of-parkinsons-disease/ 2022-11-11T13:12:05+00:00 https://medicaex.com/wp-content/uploads/2022/11/amneallogo-7sCwtf.jpeg https://medicaex.com/businesswire/tremeau-pharmaceuticals-acr-convergence-2022-presentations-highlight-potential-path-forward-for-historical-vioxx/ 2022-11-11T13:12:05+00:00 https://medicaex.com/wp-content/uploads/2022/11/Tremeau_Final_Logo_Horizontal-ZUDhaC.jpeg https://medicaex.com/businesswire/vbi-vaccines-announces-presentation-of-data-from-ongoing-phase-2a-study-of-vbi-1901-at-the-2022-society-for-neuro-oncology-sno-annual-meeting/ 2022-11-11T13:12:05+00:00 https://medicaex.com/wp-content/uploads/2022/11/VBI_Vaccines_Logo_Horiz_RGB-TIG555.jpeg https://medicaex.com/businesswire/novocure-secures-ce-mark-for-new-array/ 2022-11-11T13:12:05+00:00 https://medicaex.com/wp-content/uploads/2022/11/novocure_main405x-A3EmKB.jpeg https://medicaex.com/businesswire/click-therapeutics-announces-participation-in-upcoming-investor-conferences-in-november-and-december/ 2022-11-11T13:12:03+00:00 https://medicaex.com/wp-content/uploads/2022/11/CT_Lock-up_CMYK_Black-v7AQur.jpeg https://medicaex.com/businesswire/docgo-launches-program-to-hire-military-community-members-through-partnership-with-hiring-our-heroes/ 2022-11-11T13:12:03+00:00 https://medicaex.com/wp-content/uploads/2022/11/DocGo_Primaray_Logo_2022-VNxPuK.jpeg https://medicaex.com/businesswire/bruker-announces-quarterly-dividend-3/ 2022-11-11T12:12:18+00:00 https://medicaex.com/wp-content/uploads/2022/11/Bruker_logo-lwYbQG.jpeg https://medicaex.com/businesswire/pivot-bio-joins-aim-for-climate-as-innovation-sprint-partner/ 2022-11-11T12:12:18+00:00 https://medicaex.com/wp-content/uploads/2022/11/PIVOT_BIO_LOGO_COLOR_28129-EdilAA.jpeg https://medicaex.com/businesswire/global-synthetic-biology-market-report-2022-continued-growth-in-rd-investments-fuels-sector-researchandmarkets-com/ 2022-11-11T12:12:18+00:00 https://medicaex.com/wp-content/uploads/2022/11/logo-bHgr0r.jpeg https://medicaex.com/businesswire/global-synthetic-small-molecule-api-market-report-2022-increasing-use-of-personalized-medicine-driving-growth-researchandmarkets-com-2/ 2022-11-11T12:12:18+00:00 https://medicaex.com/wp-content/uploads/2022/11/logo-pxFO9J.jpeg https://medicaex.com/businesswire/caredx-committed-to-delivering-clinical-innovation-to-the-transplant-patient-and-physician-community/ 2022-11-11T12:12:17+00:00 https://medicaex.com/wp-content/uploads/2022/11/CareDx_Logo-oDmIR4.jpeg https://medicaex.com/businesswire/smart-healthcare-products-global-market-report-2022-featuring-airstrip-technologies-samsung-healthcare-siemens-healthineers-cerner-corporation-mckesson-researchandmarkets-com-2/ 2022-11-11T12:12:14+00:00 https://medicaex.com/wp-content/uploads/2022/11/logo-cPxmVw.jpeg https://medicaex.com/businesswire/global-prenatal-genetic-testing-market-report-2022-2026-innovation-culture-in-screening-drives-prenatal-genetic-testing-growth-and-makes-it-accessible-to-more-patients-researchandmarkets-com/ 2022-11-11T12:12:13+00:00 https://medicaex.com/wp-content/uploads/2022/11/logo-S8TPaF.jpeg https://medicaex.com/businesswire/bruker-announces-quarterly-dividend-2/ 2022-11-11T12:12:12+00:00 https://medicaex.com/wp-content/uploads/2022/11/Bruker_logo-WB87ad.jpeg https://medicaex.com/businesswire/animal-wound-care-global-market-report-2022-rising-demand-for-pet-insurance-and-growing-animal-health-expenditure-drives-sector-researchandmarkets-com/ 2022-11-11T12:12:11+00:00 https://medicaex.com/wp-content/uploads/2022/11/logo-pBbj7x.jpeg https://medicaex.com/businesswire/global-synthetic-small-molecule-api-market-report-2022-increasing-use-of-personalized-medicine-driving-growth-researchandmarkets-com/ 2022-11-11T12:12:09+00:00 https://medicaex.com/wp-content/uploads/2022/11/logo-cKcy3C.jpeg https://medicaex.com/businesswire/bruker-announces-quarterly-dividend/ 2022-11-11T12:12:08+00:00 https://medicaex.com/wp-content/uploads/2022/11/Bruker_logo-3h7uEo.jpeg https://medicaex.com/businesswire/global-diabetic-neuropathy-market-report-2022-cutting-edge-product-development-to-shape-sector-moving-forward-researchandmarkets-com/ 2022-11-11T12:12:08+00:00 https://medicaex.com/wp-content/uploads/2022/11/logo-WxQNU1.jpeg https://medicaex.com/businesswire/smart-healthcare-products-global-market-report-2022-featuring-airstrip-technologies-samsung-healthcare-siemens-healthineers-cerner-corporation-mckesson-researchandmarkets-com/ 2022-11-11T12:12:06+00:00 https://medicaex.com/wp-content/uploads/2022/11/logo-QRRbMo.jpeg https://medicaex.com/businesswire/proteomic-biomarker-analytics-global-market-report-2022-proteomics-set-to-overtake-genomics-as-new-frontier-in-biotechnology-researchandmarkets-com/ 2022-11-11T11:13:15+00:00 https://medicaex.com/wp-content/uploads/2022/11/logo-W95QVi.jpeg https://medicaex.com/businesswire/nanology-completes-enrollment-in-phase-2a-trial-of-intratumoral-lsam-ptx-with-soc-in-patients-with-nonoperable-lung-cancer-2/ 2022-11-11T11:13:15+00:00 https://medicaex.com/wp-content/uploads/2022/11/NanOlogy_logo_green_noLLC-PA76WR.jpeg https://medicaex.com/businesswire/global-endoscopy-visualization-systems-pipeline-report-2022-create-effective-counter-strategies-to-gain-competitive-advantage-researchandmarkets-com/ 2022-11-11T11:12:09+00:00 https://medicaex.com/wp-content/uploads/2022/11/logo-BdJzpr.jpeg https://medicaex.com/businesswire/nanology-completes-enrollment-in-phase-2a-trial-of-intratumoral-lsam-ptx-with-soc-in-patients-with-nonoperable-lung-cancer/ 2022-11-11T11:12:05+00:00 https://medicaex.com/wp-content/uploads/2022/11/NanOlogy_logo_green_noLLC-9t6HID.jpeg https://medicaex.com/businesswire/asia-pacific-precision-diagnostics-market-report-2022-surging-demand-for-personalized-medicine-drives-growth-researchandmarkets-com-2/ 2022-11-11T10:12:11+00:00 https://medicaex.com/wp-content/uploads/2022/11/logo-9JAQWj.jpeg https://medicaex.com/businesswire/asia-pacific-precision-diagnostics-market-report-2022-surging-demand-for-personalized-medicine-drives-growth-researchandmarkets-com/ 2022-11-11T10:12:10+00:00 https://medicaex.com/wp-content/uploads/2022/11/logo-kSvLEB.jpeg https://medicaex.com/businesswire/european-commission-ec-approves-livtencitytm%e2%96%bc-maribavir-for-the-treatment-of-adults-with-post-transplant-cytomegalovirus-cmv-infection-and-or-disease-that-are-refractory-with-or-without-2/ 2022-11-11T07:12:13+00:00 https://medicaex.com/wp-content/uploads/2022/11/3472696_BrandSymbol_Dakiyama_Rd-HCaPpB.jpeg https://medicaex.com/businesswire/european-commission-ec-approves-livtencitytm%e2%96%bc-maribavir-for-the-treatment-of-adults-with-post-transplant-cytomegalovirus-cmv-infection-and-or-disease-that-are-refractory-with-or-without/ 2022-11-11T07:12:07+00:00 https://medicaex.com/wp-content/uploads/2022/11/3472696_BrandSymbol_Dakiyama_Rd-KC8Tau.jpeg https://medicaex.com/businesswire/rallybio-announces-pricing-of-50-million-public-offering/ 2022-11-11T05:12:09+00:00 https://medicaex.com/wp-content/uploads/2022/11/Press_Release_Logo-Y4inFc.jpeg https://medicaex.com/businesswire/kirin-holdings-and-kao-begin-joint-research-on-the-relationship-between-visceral-fat-and-immunology-2/ 2022-11-11T02:12:12+00:00 https://medicaex.com/wp-content/uploads/2022/11/new_kirin_E_finalE88BB1E69687E383ADE382B4-DCVzyI.jpeg https://medicaex.com/businesswire/kirin-holdings-and-kao-begin-joint-research-on-the-relationship-between-visceral-fat-and-immunology/ 2022-11-11T02:12:05+00:00 https://medicaex.com/wp-content/uploads/2022/11/new_kirin_E_finalE88BB1E69687E383ADE382B4-coCis7.jpeg https://medicaex.com/businesswire/elysian-wellness-veteran-owned-ketamine-clinic-celebrates-1-year-anniversary/ 2022-11-11T02:12:05+00:00 https://medicaex.com/wp-content/uploads/2022/11/elysian_wellness_full_green_rgb_28129-MmMIQ2.jpeg https://medicaex.com/businesswire/scipher-medicine-announces-publication-of-positive-results-from-aims-clinical-study/ 2022-11-11T01:12:09+00:00 https://medicaex.com/wp-content/uploads/2022/11/Scipher_Corporate-iKTHJB.jpeg https://medicaex.com/businesswire/tandem-diabetes-care-study-demonstrates-improvements-of-all-clinical-endpoints-in-adults-with-type-2-diabetes-using-control-iq-technology-2/ 2022-11-10T23:12:10+00:00 https://medicaex.com/wp-content/uploads/2022/11/2022_02_01_Tandem_Horizontal_Logo_New_RGB-Rxx2a4.jpeg https://medicaex.com/businesswire/tandem-diabetes-care-study-demonstrates-improvements-of-all-clinical-endpoints-in-adults-with-type-2-diabetes-using-control-iq-technology/ 2022-11-10T23:12:08+00:00 https://medicaex.com/wp-content/uploads/2022/11/2022_02_01_Tandem_Horizontal_Logo_New_RGB-9hJVkZ.jpeg https://medicaex.com/businesswire/precision-biosciences-announces-change-to-its-board-of-directors/ 2022-11-10T22:12:14+00:00 https://medicaex.com/wp-content/uploads/2022/11/Precision_BioSciences_logo-8xycw9.jpeg https://medicaex.com/businesswire/reata-pharmaceuticals-announces-participation-in-the-guggenheim-2022-immunology-and-neurology-conference-and-the-stifel-2022-healthcare-conference-2/ 2022-11-10T22:12:14+00:00 https://medicaex.com/wp-content/uploads/2022/11/REATA_PHARM_Normal_LOGO-yQF79z.jpeg https://medicaex.com/businesswire/thermo-fisher-scientific-authorizes-4-billion-of-share-repurchases-4/ 2022-11-10T22:12:14+00:00 https://medicaex.com/wp-content/uploads/2022/11/Thermo_Fisher_Scientific-cuA2Y1.jpeg https://medicaex.com/businesswire/cutera-inc-to-participate-in-a-fireside-chat-at-the-stifel-healthcare-2022-conference-3/ 2022-11-10T22:12:13+00:00 https://medicaex.com/businesswire/thermo-fisher-scientific-authorizes-4-billion-of-share-repurchases-3/ 2022-11-10T22:12:11+00:00 https://medicaex.com/wp-content/uploads/2022/11/Thermo_Fisher_Scientific-dYVkte.jpeg https://medicaex.com/businesswire/thermo-fisher-scientific-declares-quarterly-dividend-2/ 2022-11-10T22:12:11+00:00 https://medicaex.com/wp-content/uploads/2022/11/Thermo_Fisher_Scientific-a4APdM.jpeg https://medicaex.com/businesswire/cutera-inc-to-participate-in-a-fireside-chat-at-the-stifel-healthcare-2022-conference-2/ 2022-11-10T22:12:10+00:00 https://medicaex.com/businesswire/thermo-fisher-scientific-authorizes-4-billion-of-share-repurchases-2/ 2022-11-10T22:12:09+00:00 https://medicaex.com/wp-content/uploads/2022/11/Thermo_Fisher_Scientific-Uc2tTX.jpeg https://medicaex.com/businesswire/thermo-fisher-scientific-declares-quarterly-dividend/ 2022-11-10T22:12:09+00:00 https://medicaex.com/wp-content/uploads/2022/11/Thermo_Fisher_Scientific-HF6tSf.jpeg https://medicaex.com/businesswire/infusystem-to-participate-at-13th-annual-craig-hallum-alpha-select-conference-on-november-17-2022-2/ 2022-11-10T22:12:09+00:00 https://medicaex.com/wp-content/uploads/2022/11/InfuSystem_SAFE.SMART_.TRUSTED._PMSC_Stacked_10-19-4yiKGG.jpeg https://medicaex.com/businesswire/cutera-inc-to-participate-in-a-fireside-chat-at-the-stifel-healthcare-2022-conference/ 2022-11-10T22:12:08+00:00 https://medicaex.com/businesswire/cutera-inc-to-participate-in-a-fireside-chat-at-the-stephens-annual-investment-conference/ 2022-11-10T22:12:07+00:00 https://medicaex.com/businesswire/infusystem-to-participate-at-13th-annual-craig-hallum-alpha-select-conference-on-november-17-2022/ 2022-11-10T22:12:07+00:00 https://medicaex.com/wp-content/uploads/2022/11/InfuSystem_SAFE.SMART_.TRUSTED._PMSC_Stacked_10-19-z6jSzn.jpeg https://medicaex.com/businesswire/thermo-fisher-scientific-authorizes-4-billion-of-share-repurchases/ 2022-11-10T22:12:05+00:00 https://medicaex.com/wp-content/uploads/2022/11/Thermo_Fisher_Scientific-MwmsX3.jpeg https://medicaex.com/businesswire/revelation-biosciences-inc-announces-financial-results-for-the-three-and-nine-months-ended-september-30-2022-and-recent-corporate-progress/ 2022-11-10T22:12:05+00:00 https://medicaex.com/wp-content/uploads/2022/11/revelation-6Irbvm.jpeg https://medicaex.com/businesswire/quanterix-to-participate-in-the-canaccord-medtech-diagnostics-and-digital-health-services-forum/ 2022-11-10T22:12:05+00:00 https://medicaex.com/wp-content/uploads/2022/11/Quanterix_Logo-MZfo1o.jpeg https://medicaex.com/businesswire/reata-pharmaceuticals-announces-participation-in-the-guggenheim-2022-immunology-and-neurology-conference-and-the-stifel-2022-healthcare-conference/ 2022-11-10T22:12:04+00:00 https://medicaex.com/wp-content/uploads/2022/11/REATA_PHARM_Normal_LOGO-C5KPgC.jpeg https://medicaex.com/businesswire/astria-therapeutics-reports-third-quarter-2022-financial-results-and-provides-a-corporate-update-2/ 2022-11-10T21:12:17+00:00 https://medicaex.com/wp-content/uploads/2022/11/Astria_logo-J2jA4U.jpeg https://medicaex.com/businesswire/lineage-cell-therapeutics-reports-third-quarter-2022-financial-results-and-provides-business-update-2/ 2022-11-10T21:12:17+00:00 https://medicaex.com/wp-content/uploads/2022/11/LINEAGE_SCREEN_JPEG_1800x360-qBRZ8s.jpeg https://medicaex.com/businesswire/agex-therapeutics-reports-third-quarter-2022-financial-results-2/ 2022-11-10T21:12:17+00:00 https://medicaex.com/wp-content/uploads/2022/11/AGEX_logo_400x400-4kWT1X.jpeg https://medicaex.com/businesswire/savara-reports-third-quarter-2022-financial-results-and-provides-business-update-2/ 2022-11-10T21:12:17+00:00 https://medicaex.com/wp-content/uploads/2022/11/Savara_Logo_2800229-SX3tHI.jpeg https://medicaex.com/businesswire/biocept-reports-second-quarter-2022-financial-results-2/ 2022-11-10T21:12:17+00:00 https://medicaex.com/businesswire/akili-reports-third-quarter-2022-financial-results-and-company-update/ 2022-11-10T21:12:13+00:00 https://medicaex.com/wp-content/uploads/2022/11/Akili_Logo-ezeTH5.jpeg https://medicaex.com/businesswire/heartbeam-reports-third-quarter-2022-financial-results-3/ 2022-11-10T21:12:13+00:00 https://medicaex.com/wp-content/uploads/2022/11/BEAT_Logo-VVkzjt.jpeg https://medicaex.com/businesswire/doximity-announces-fiscal-2023-second-quarter-financial-results/ 2022-11-10T21:12:13+00:00 https://medicaex.com/wp-content/uploads/2022/11/Doximity_Logo_BW-KN3Q4j.jpeg https://medicaex.com/businesswire/myomo-reports-third-quarter-2022-financial-results-featuring-strong-authorizations-and-orders-and-record-backlog-2/ 2022-11-10T21:12:12+00:00 https://medicaex.com/wp-content/uploads/2022/11/Myomo_tag_28529-fpL6ab.jpeg https://medicaex.com/businesswire/pulse-biosciences-reports-third-quarter-2022-financial-results-2/ 2022-11-10T21:12:12+00:00 https://medicaex.com/wp-content/uploads/2022/11/pulse-logo-E688kD.jpeg https://medicaex.com/businesswire/myomo-reports-third-quarter-2022-financial-results-featuring-strong-authorizations-and-orders-and-record-backlog/ 2022-11-10T21:12:10+00:00 https://medicaex.com/wp-content/uploads/2022/11/Myomo_tag_28529-GJLGfo.jpeg https://medicaex.com/businesswire/agiliti-announces-financial-results-for-third-quarter-2022/ 2022-11-10T21:12:10+00:00 https://medicaex.com/wp-content/uploads/2022/11/Agiliti_COLOR-bshhJC.jpeg https://medicaex.com/businesswire/pulse-biosciences-reports-third-quarter-2022-financial-results/ 2022-11-10T21:12:10+00:00 https://medicaex.com/wp-content/uploads/2022/11/pulse-logo-MCiX3K.jpeg https://medicaex.com/businesswire/paragon-28-reports-third-quarter-2022-financial-results-and-increases-2022-net-revenue-guidance/ 2022-11-10T21:12:10+00:00 https://medicaex.com/businesswire/heartbeam-reports-third-quarter-2022-financial-results-2/ 2022-11-10T21:12:10+00:00 https://medicaex.com/wp-content/uploads/2022/11/BEAT_Logo-8n4FT9.jpeg https://medicaex.com/businesswire/figs-releases-third-quarter-2022-financial-results/ 2022-11-10T21:12:08+00:00 https://medicaex.com/businesswire/healthwarehouse-com-reports-results-for-third-quarter-2022/ 2022-11-10T21:12:08+00:00 https://medicaex.com/businesswire/koru-medical-systems-to-participate-in-upcoming-investor-conferences/ 2022-11-10T21:12:08+00:00 https://medicaex.com/businesswire/savara-reports-third-quarter-2022-financial-results-and-provides-business-update/ 2022-11-10T21:12:06+00:00 https://medicaex.com/wp-content/uploads/2022/11/Savara_Logo_2800229-Px72nq.jpeg https://medicaex.com/businesswire/biocept-reports-second-quarter-2022-financial-results/ 2022-11-10T21:12:06+00:00 https://medicaex.com/businesswire/astria-therapeutics-reports-third-quarter-2022-financial-results-and-provides-a-corporate-update/ 2022-11-10T21:12:05+00:00 https://medicaex.com/wp-content/uploads/2022/11/Astria_logo-ZRsfKx.jpeg https://medicaex.com/businesswire/lineage-cell-therapeutics-reports-third-quarter-2022-financial-results-and-provides-business-update/ 2022-11-10T21:12:05+00:00 https://medicaex.com/wp-content/uploads/2022/11/LINEAGE_SCREEN_JPEG_1800x360-efrNSZ.jpeg https://medicaex.com/businesswire/agex-therapeutics-reports-third-quarter-2022-financial-results/ 2022-11-10T21:12:05+00:00 https://medicaex.com/wp-content/uploads/2022/11/AGEX_logo_400x400-OI3ujQ.jpeg https://medicaex.com/businesswire/heartbeam-reports-third-quarter-2022-financial-results/ 2022-11-10T21:12:03+00:00 https://medicaex.com/wp-content/uploads/2022/11/BEAT_Logo-eGWXYY.jpeg https://medicaex.com/businesswire/biogx-expands-fda-eua-with-pixl-portable-qpcr-system-for-its-direct-sample-covid-19-assay-4/ 2022-11-10T20:12:10+00:00 https://medicaex.com/wp-content/uploads/2022/11/BioGX_-_New_Logo_-_final-0AzbL7.jpeg https://medicaex.com/businesswire/biogx-expands-fda-eua-with-pixl-portable-qpcr-system-for-its-direct-sample-covid-19-assay-3/ 2022-11-10T20:12:07+00:00 https://medicaex.com/wp-content/uploads/2022/11/BioGX_-_New_Logo_-_final-6a1hUB.jpeg https://medicaex.com/businesswire/biogx-expands-fda-eua-with-pixl-portable-qpcr-system-for-its-direct-sample-covid-19-assay-2/ 2022-11-10T20:12:06+00:00 https://medicaex.com/wp-content/uploads/2022/11/BioGX_-_New_Logo_-_final-l8gwiP.jpeg https://medicaex.com/businesswire/biogx-expands-fda-eua-with-pixl-portable-qpcr-system-for-its-direct-sample-covid-19-assay/ 2022-11-10T20:12:04+00:00 https://medicaex.com/wp-content/uploads/2022/11/BioGX_-_New_Logo_-_final-5obo6V.jpeg https://medicaex.com/businesswire/global-cell-expansion-market-report-2022-rising-preference-for-gene-therapy-and-use-of-biologics-drives-growth-researchandmarkets-com-2/ 2022-11-10T19:12:11+00:00 https://medicaex.com/wp-content/uploads/2022/11/logo-XOSQYF.jpeg https://medicaex.com/businesswire/seagen-announces-u-s-fda-approval-of-new-indication-for-adcetris-brentuximab-vedotin-for-children-with-previously-untreated-high-risk-hodgkin-lymphoma-2/ 2022-11-10T19:12:11+00:00 https://medicaex.com/wp-content/uploads/2022/11/Seagen_Logo_RGB-WKdxQ1.jpeg https://medicaex.com/businesswire/gigxr-holoscenarios-named-to-times-list-of-the-best-inventions-of-2022-recognizes-holographic-patient-simulation-as-life-changing-innovation-2/ 2022-11-10T19:12:09+00:00 https://medicaex.com/wp-content/uploads/2022/11/Unknown-azQUr2.jpeg https://medicaex.com/businesswire/sleep-apnea-diagnostic-devices-market-report-2022-technological-developments-in-devices-to-offer-more-comfort-driving-adoption-researchandmarkets-com-2/ 2022-11-10T19:12:08+00:00 https://medicaex.com/wp-content/uploads/2022/11/logo-gRF1gK.jpeg https://medicaex.com/businesswire/sleep-apnea-diagnostic-devices-market-report-2022-technological-developments-in-devices-to-offer-more-comfort-driving-adoption-researchandmarkets-com/ 2022-11-10T19:12:07+00:00 https://medicaex.com/wp-content/uploads/2022/11/logo-X2GCww.jpeg https://medicaex.com/businesswire/global-cell-expansion-market-report-2022-rising-preference-for-gene-therapy-and-use-of-biologics-drives-growth-researchandmarkets-com/ 2022-11-10T19:12:05+00:00 https://medicaex.com/wp-content/uploads/2022/11/logo-fy4KpQ.jpeg